30 research outputs found
Conjugated Linoleic Acid and Brain Metabolism: A Possible Anti-Neuroinflammatory Role Mediated by PPARα Activation
Fatty acids play a crucial role in the brain as specific receptor ligands and as precursors of
bioactive metabolites. Conjugated linoleic acid (CLA), a group of positional and geometric
isomers of linoleic acid (LA, 18:2 n-6) present in meat and dairy products of ruminants and
synthesized endogenously in non-ruminants and humans, has been shown to possess
different nutritional properties associated with health benefits. Its ability to bind to
peroxisome proliferator-activated receptor (PPAR)
α, a nuclear receptor key regulator of
fatty acid metabolism and inflammatory responses, partly mediates these beneficial effects.
CLA is incorporated and metabolized into brain tissue where induces the biosynthesis of
endogenous PPAR
α ligands palmitoylethanolamide (PEA) and oleoylethanolamide (OEA),
likely through a positive feedback mechanism where PPAR
α activation sustains its own
cellular effects through ligand biosynthesis. In addition to PPAR
α, PEA and OEA may as well
bind to other receptors such as TRPV1, further extending CLA own anti-neuroinflammatory
actions. Future studies are needed to investigate whether dietary CLA may exert antiinflammatory
activity, particularly in the setting of neurodegenerative diseases and
neuropsychiatric disorders with a neuroinflammatory basis
Recommended from our members
Digital and physical spaces in informal settlements: migrants, refugee camps and mapping
Design tools to help understand the migratory journeys and experiences of individuals and communities from countries in crisis heading towards Europe have been well documented and studied in recent years. In particular, the use of new media (social media) and related technologies, like mobile phones, has recently become a useful instrument of connection between individuals with both shared and different cultural, ethnic, and linguistic backgrounds.The existing literature can be divided into two main categories: the studies that focus on using new and traditional media to trace and record both individual and communities’ experiences on their journey, and those that examine and propose new technologies to create maps and log the details of the journey and their connectivity, and a more intersubjective experience.Existing studies are therefore helpful in providing insights into both the physical journey and the individual experience of it. However, they are limited to the data available and to the traditional ways employed to elicit information from individuals in transit, including refugees. A large number of individuals are less represented within these studies, and often their stories are not told in a subjective manner. New ways of eliciting information, mapping individual experiences and gathering and interpreting data are necessary.In this chapter we present an analysis of a case study in which refugees in Calais, northern France have actively contributed to group initiatives involving physical and digital mapping. Using this case study as a starting point, we elaborate on ways in which new and advanced technologies could be used to improve communication between refugees and the charities and volunteers working with them. This chapter explores ways in which such data can be gathered in order to have new insights into the experience of refugees in camps and informal settlements through new technologies. We reflect on new ways in which maps can be drawn and relationships of individuals with the territories that they temporarily inhabit are formed and recorded
Atypical Bartonella henselae neuroretinitis in an immunocompetent patient.
We report a case of a 57-year-old immunocompetent male, admitted to our Department due to the loss of visual acuity to the
right eye, occurred during the two weeks before the hospitalization, and hyperglycaemia. Our patient suffered from metabolic syndrome,
characterized by visceral obesity, impaired glucose tolerance, arterial hypertension, complicated by proteinuria, and moderate
grade hypertensive retinopathy. Surprisingly, and despite its many comorbidities, the final diagnosis was neuroretinitis by
Bartonella henselae, without any other symptoms/signs of cat-scratch disease. The patient denied any kind of contact with cats. He
was cured by specific antibiotic therapy, restoring status ‘quo ante’
Risk of low bone mineral density and low body mass index in patients with non-celiac wheat-sensitivity: a prospective observation study.
Background: Non-celiac gluten sensitivity (NCGS) or ‘wheat sensitivity’ (NCWS) is included in the spectrum of gluten-related disorders. No data are available on the prevalence of low bone mass density (BMD) in NCWS. Our study aims to evaluate the prevalence of low BMD in NCWS patients and search for correlations with other clinical characteristics.
Methods: This prospective observation study included 75 NCWS patients (63 women; median age 36 years) with irritable bowel syndrome (IBS)-like symptoms, 65 IBS and 50 celiac controls. Patients were recruited at two Internal Medicine Departments. Elimination diet and double-blind placebo controlled (DBPC) wheat challenge proved the NCWS diagnosis. All subjects underwent BMD assessment by Dual Energy X-Ray Absorptiometry (DXA), duodenal histology, HLA DQ typing, body mass index (BMI) evaluation and assessment for daily calcium intake.
Results: DBPC cow's milk proteins challenge showed that 30 of the 75 NCWS patients suffered from multiple food sensitivity. Osteopenia and osteoporosis frequency increased from IBS to NCWS and to celiac disease (CD)
(P <0.0001). Thirty-five NCWS patients (46.6%) showed osteopenia or osteoporosis. Low BMD was related to low BMI and multiple food sensitivity. Values of daily dietary calcium intake in NCWS patients were significantly lower than in IBS controls.
Conclusions: An elevated frequency of bone mass loss in NCWS patients was found; this was related to low BMI and was more frequent in patients with NCWS associated with other food sensitivity. A low daily intake of dietary calcium was observed in patients with NCWS
Evaluation of “Caterina assay”: An Alternative Tool to the Commercialized Kits Used for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Identification
Abstract: Here we describe the first molecular test developed in the early stage of the pandemic to
diagnose the first cases of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
in Sardinian patients in February–March 2020, when diagnostic certified methodology had not yet
been adopted by clinical microbiology laboratories. The “Caterina assay” is a SYBR®Green real-time
reverse-transcription polymerase chain reaction (rRT-PCR), designed to detect the nucleocapsid
phosphoprotein (N) gene that exhibits high discriminative variation RNA sequence among bat and
human coronaviruses. The molecular method was applied to detect SARS-CoV-2 in nasal swabs
collected from 2110 suspected cases. The study article describes the first molecular test developed
in the early stage of the declared pandemic to identify the coronavirus disease 2019 (COVID-19) in
Sardinian patients in February–March 2020, when a diagnostic certified methodology had not yet been
adopted by clinical microbiology laboratories. The assay presented high specificity and sensitivity
(with a detection limit ≥50 viral genomes/µL). No false-positives were detected, as confirmed by the
comparison with two certified commercial kits. Although other validated molecular methods are
currently in use, the Caterina assay still represents a valid and low-cost detection procedure that could
be applied in countries with limited economic resource
PPAR-Alpha Agonists as Novel Antiepileptic Drugs: Preclinical Findings
Nicotinic acetylcholine receptors (nAChRs) are involved in seizure mechanisms. Hence, nocturnal frontal lobe epilepsy was
the first idiopathic epilepsy linked with specific mutations in a4 or b2 nAChR subunit genes. These mutations confer gain of
function to nAChRs by increasing sensitivity toward acetylcholine. Consistently, nicotine elicits seizures through nAChRs and
mimics the excessive nAChR activation observed in animal models of the disease. Treatments aimed at reducing nicotinic
inputs are sought as therapies for epilepsies where these receptors contribute to neuronal excitation and synchronization.
Previous studies demonstrated that peroxisome proliferator-activated receptors-a (PPARa), nuclear receptor transcription
factors, suppress nicotine-induced behavioral and electrophysiological effects by modulating nAChRs containing b2
subunits. On these bases, we tested whether PPARa agonists were protective against nicotine-induced seizures. To this aim
we utilized behavioral and electroencephalographic (EEG) experiments in C57BL/J6 mice and in vitro patch clamp
recordings from mice and rats. Convulsive doses of nicotine evoked severe seizures and bursts of spike-waves discharges in
,100% of mice. A single dose of the synthetic PPARa agonist WY14643 (WY, 80 mg/kg, i.p.) or chronic administration of
fenofibrate, clinically available for lipid metabolism disorders, in the diet (0.2%) for 14 days significantly reduced or
abolished behavioral and EEG expressions of nicotine-induced seizures. Acute WY effects were reverted by the PPARa
antagonist MK886 (3 mg/kg, i.p.). Since neocortical networks are crucial in the generation of ictal activity and synchrony, we
performed patch clamp recordings of spontaneous inhibitory postsynaptic currents (sIPSCs) from frontal cortex layer II/III
pyramidal neurons. We found that both acute and chronic treatment with PPARa agonists abolished nicotine-induced sIPSC
increases. PPARa within the CNS are key regulators of neuronal activity through modulation of nAChRs. These effects might
be therapeutically exploited for idiopathic or genetically determined forms of epilepsy where nAChRs play a major role
CRISIS AFAR: an international collaborative study of the impact of the COVID-19 pandemic on mental health and service access in youth with autism and neurodevelopmental conditions
BackgroundHeterogeneous mental health outcomes during the COVID-19 pandemic are documented in the general population. Such heterogeneity has not been systematically assessed in youth with autism spectrum disorder (ASD) and related neurodevelopmental disorders (NDD). To identify distinct patterns of the pandemic impact and their predictors in ASD/NDD youth, we focused on pandemic-related changes in symptoms and access to services.MethodsUsing a naturalistic observational design, we assessed parent responses on the Coronavirus Health and Impact Survey Initiative (CRISIS) Adapted For Autism and Related neurodevelopmental conditions (AFAR). Cross-sectional AFAR data were aggregated across 14 European and North American sites yielding a clinically well-characterized sample of N = 1275 individuals with ASD/NDD (age = 11.0 ± 3.6 years; n females = 277). To identify subgroups with differential outcomes, we applied hierarchical clustering across eleven variables measuring changes in symptoms and access to services. Then, random forest classification assessed the importance of socio-demographics, pre-pandemic service rates, clinical severity of ASD-associated symptoms, and COVID-19 pandemic experiences/environments in predicting the outcome subgroups.ResultsClustering revealed four subgroups. One subgroup-broad symptom worsening only (20%)-included youth with worsening across a range of symptoms but with service disruptions similar to the average of the aggregate sample. The other three subgroups were, relatively, clinically stable but differed in service access: primarily modified services (23%), primarily lost services (6%), and average services/symptom changes (53%). Distinct combinations of a set of pre-pandemic services, pandemic environment (e.g., COVID-19 new cases, restrictions), experiences (e.g., COVID-19 Worries), and age predicted each outcome subgroup.LimitationsNotable limitations of the study are its cross-sectional nature and focus on the first six months of the pandemic.ConclusionsConcomitantly assessing variation in changes of symptoms and service access during the first phase of the pandemic revealed differential outcome profiles in ASD/NDD youth. Subgroups were characterized by distinct prediction patterns across a set of pre- and pandemic-related experiences/contexts. Results may inform recovery efforts and preparedness in future crises; they also underscore the critical value of international data-sharing and collaborations to address the needs of those most vulnerable in times of crisis